BiotechTubeBiotechTube
Home/HilleVax/David Socks
DS

David Socks

Chief Financial Officer and Director

HilleVax

Therapeutic Areas

Infectious DiseaseVaccines

HilleVax Pipeline

DrugIndicationPhase
HIL-214Prevention of moderate-to-severe acute gastroenteritis caused by norovirus infectionPhase 2b/3

Leadership Team at HilleVax

RH
Rob Hershberg
Executive Chairman of the Board
AB
A. Bruce Montgomery
Chief Executive Officer and Director
AK
Aditya Kohli
Chief Operating Officer
PB
Paul Bavier
General Counsel
J(
James (Jim) F. Young
Chief Scientific Officer
SG
Sheila Gujrathi
Former Chief Executive Officer
EO
Elaine O'Hara
Director
JP
John P. Richard
Director
MK
Michael Kamarck
Director
TL
Teri Loxam
Director
View full HilleVax profile